Paper Details

  1. Home
  2. Paper Details

Treatment Patterns of Lipid-Lowering Therapy in Patients with Coronary Artery Disease Aged Above and Below 75 Years: A Retrospective Cross-Sectional Study of 1500 Patients in a Tertiary Care Referral Center in Germany.

Author: Al-RashidFadi, DykunIryna, HendricksStefanie, JánosiR Alexander, MahabadiAmir A, RassafTienush, TotzeckMatthias, WiefhoffDaniela

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Elderly patients with coronary artery disease (CAD) face unique challenges in lipid-lowering therapy, requiring careful consideration of potential benefits and risks. This study examines treatment patterns in elderly CAD patients compared to younger patients.
Paper Details　
Original Abstract of the Article :
Lipid-lowering therapy of elderly patients with coronary artery disease (CAD) inherits a medical challenge, as these patients experience a higher absolute risk reduction but may be more prone to side effects. We aimed to evaluate the treatment patterns in lipid-lowering therapy, comparing CAD patien...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320066/

データ提供：米国国立医学図書館（NLM）

Lipid-Lowering Therapy for Elderly Patients with Coronary Artery Disease

This study investigates the treatment patterns of lipid-lowering therapy in patients with coronary artery disease (CAD) aged above and below 75 years. The researchers conducted a retrospective cross-sectional study of 1500 patients at a tertiary care referral center in Germany to compare the treatment approaches for elderly patients with CAD to those younger than 75 years. They aimed to understand the challenges and considerations involved in managing lipid levels in this vulnerable population.

Lipid-Lowering Therapy for Elderly Patients with CAD

The study highlights the challenges of managing lipid levels in elderly patients with CAD. The researchers found that while elderly patients with CAD experience higher absolute risk reduction with lipid-lowering therapy, they may also be more susceptible to side effects. This underscores the need for individualized treatment plans that carefully balance the potential benefits and risks of therapy.

Personalized Treatment Plans for Elderly Patients

The study emphasizes the importance of personalized treatment plans for elderly patients with CAD. This involves a comprehensive assessment of individual patient factors, such as age, overall health status, and potential drug interactions, to determine the most appropriate lipid-lowering therapy. This research underscores the need for careful consideration of patient-specific needs and the potential risks and benefits of treatment.

Dr.Camel's Conclusion

Just as a camel navigates a rugged desert path with careful steps, healthcare providers must navigate the complexities of managing lipid levels in elderly patients with CAD. This study highlights the need for individualized treatment plans, balancing the potential benefits of therapy with the importance of patient safety. This research emphasizes the importance of a personalized and holistic approach to managing this complex condition.

Date :
  1. Date Completed 2020-11-30
  2. Date Revised 2021-06-14
Further Info :

Pubmed ID

32468428

DOI: Digital Object Identifier

PMC7320066

Related Literature

Article Analysis
・Side Effects of simvastatin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.